AUGUST 2024LIFE SCIENCES REVIEW 519Henry David Cremisi, MD FACP,Executive Medical Director, Medical Affairs,CaidyaThe Rub: Medical Affairs is Far More than a Commodity in Rare and Genetic Disease22Samir Ounzain, Co-founder, Chief Executive Officer & Board Director, HAYA TherapeuticsThe Dark Side of the Genome Transforming RNA Therapies24Matthew (Matt) Hewitt,Vice President, CTO Manufacturing,Charles River LaboratoriesThe Future of the Life Sciences Industry26Carrie Lewis,Executive Director, Clinical Program Optimization,Endo PharmaceuticalsFlexibility to Change is the Key to Successful Pharma Projects28Tamara J. Laskowski,Global Head, Clinical & Process Development,Lonza Personalized Medicine,LonzaConquering Challenges And Broadening Opportunities: The Journey To Bringing Innovative Cell Therapies To PatientsFEATURED COMPANYCXO INSIGHTSCXO INSIGHTS18Safe Harbor Psychiatry LLCCarly Ramos,Psychiatric Nurse Practitioner and ManagerGENETIC TESTINGTOP 10SERVICES PROVIDERS - 2024
< Page 4 | Page 6 >